| Financial Year |
March 31 2022 |
| Monetary Funds |
1,018,653,523.45 |
| Held-for-trading Financial Assets |
309,293,272.97 |
| Notes Receivable |
-- |
| Accounts Receivable |
199,980,616.23 |
| Advances to Suppliers |
3,120,674.19 |
| Other Receivables |
5,087,149.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
44,884,210.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
60,204,203.18 |
| Total Current Assets |
1,795,450,343.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
212,647,437.22 |
| Investment Properties |
-- |
| Fixed Assetes |
1,626,492,447.48 |
| Under-construction Projects |
74,827,476.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
828,376,003.29 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
13,109,991.16 |
| Deferred Income Tax Assets |
95,762,045.05 |
| Other Non-Current Assets |
979,720,595.09 |
| Sub-Total of Non-Current Assets |
3,862,483,980.89 |
| Total Assets |
5,657,934,324.38 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
8,000,000.00 |
| Accounts Payable |
331,119,623.51 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
57,599,320.34 |
| Taxes Payable |
37,718,108.21 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
72,050,322.24 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
163,270,029.00 |
| Other Current Liabilities |
56,303,698.72 |
| Sub-Total of Current Liabilities |
1,231,974,166.38 |
| Long-term Loans |
-- |
| Bonds Payable |
584,603,964.89 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,844,461.39 |
| Other Non-Current Liabilities |
430,698,041.67 |
| Sub-Total of Non-Current Liabilities |
1,071,709,711.51 |
| Total Liabilities |
2,303,683,877.89 |
| Paid-In Capital(Or Share Stock) |
935,210,292.00 |
| Capital Surplus |
391,468,425.60 |
| Surplus Reserve |
230,473,205.09 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,746,932,047.30 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,354,250,446.49 |
| Owner's Equity（Stockholder's Equity） |
3,354,250,446.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,657,934,324.38 |
